Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 24276320)

1.

New aspects of gene-silencing for the treatment of cardiovascular diseases.

Koenig O, Walker T, Perle N, Zech A, Neumann B, Schlensak C, Wendel HP, Nolte A.

Pharmaceuticals (Basel). 2013 Jul 19;6(7):881-914. doi: 10.3390/ph6070881.

2.

The role of microRNAs in cardiovascular disease.

Aghabozorg Afjeh SS, Ghaderian SM.

Int J Mol Cell Med. 2013 Spring;2(2):50-7. Review.

3.

Disease-causing allele-specific silencing by RNA interference.

Hohjoh H.

Pharmaceuticals (Basel). 2013 Apr 11;6(4):522-35. doi: 10.3390/ph6040522.

4.

RNAi Therapeutic Platforms for Lung Diseases.

Fujita Y, Takeshita F, Kuwano K, Ochiya T.

Pharmaceuticals (Basel). 2013 Feb 6;6(2):223-50. doi: 10.3390/ph6020223.

5.

Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection.

Freeley M, Long A.

Biochem J. 2013 Oct 15;455(2):133-47. doi: 10.1042/BJ20130950.

PMID:
24070422
6.

RNA interference: A futuristic tool and its therapeutic applications.

Ambesajir A, Kaushik A, Kaushik JJ, Petros ST.

Saudi J Biol Sci. 2012 Oct;19(4):395-403. doi: 10.1016/j.sjbs.2012.08.001. Epub 2012 Aug 17.

7.

Western blot evaluation of siRNA delivery by pH-responsive peptides.

Liang W, Mason AJ, Lam JK.

Methods Mol Biol. 2013;986:73-87. doi: 10.1007/978-1-62703-311-4_5.

8.

Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells.

Novobrantseva TI, Borodovsky A, Wong J, Klebanov B, Zafari M, Yucius K, Querbes W, Ge P, Ruda VM, Milstein S, Speciner L, Duncan R, Barros S, Basha G, Cullis P, Akinc A, Donahoe JS, Narayanannair Jayaprakash K, Jayaraman M, Bogorad RL, Love K, Whitehead K, Levins C, Manoharan M, Swirski FK, Weissleder R, Langer R, Anderson DG, de Fougerolles A, Nahrendorf M, Koteliansky V.

Mol Ther Nucleic Acids. 2012 Jan 24;1:e4. doi: 10.1038/mtna.2011.3.

9.

RNA interference--a silent but an efficient therapeutic tool.

Ramachandran PV, Ignacimuthu S.

Appl Biochem Biotechnol. 2013 Mar;169(6):1774-89. doi: 10.1007/s12010-013-0098-1. Epub 2013 Jan 23. Review.

PMID:
23340870
10.

Therapeutic gene targeting approaches for the treatment of dyslipidemias and atherosclerosis.

Mäkinen PI, Ylä-Herttuala S.

Curr Opin Lipidol. 2013 Apr;24(2):116-22. doi: 10.1097/MOL.0b013e32835da13c. Review.

PMID:
23314926
11.

The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.

Chang C, Hong SW, Dua P, Kim S, Lee DK.

Methods Mol Biol. 2013;942:135-52. doi: 10.1007/978-1-62703-119-6_7.

PMID:
23027049
12.

[Research progress on the development of the strategies for siRNAs delivery in vivo].

Tang D, Mao A.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Aug;29(4):775-9. Review. Chinese.

PMID:
23016434
13.

RNAi-mediated gene silencing in cancer therapy.

Yang WQ, Zhang Y.

Expert Opin Biol Ther. 2012 Nov;12(11):1495-504. doi: 10.1517/14712598.2012.712107. Epub 2012 Jul 31.

PMID:
22849542
14.

Therapeutic implications of small interfering RNA in cardiovascular diseases.

Raghunathan S, Patel BM.

Fundam Clin Pharmacol. 2013 Feb;27(1):1-20. doi: 10.1111/j.1472-8206.2012.01051.x. Epub 2012 Jul 4. Review.

PMID:
22762243
15.

DNA vector-based RNA interference to study gene function in cancer.

Stovall DB, Wan M, Zhang Q, Dubey P, Sui G.

J Vis Exp. 2012 Jun 4;(64):e4129. doi: 10.3791/4129.

16.

Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.

Lee SH, Chung BH, Park TG, Nam YS, Mok H.

Acc Chem Res. 2012 Jul 17;45(7):1014-25. doi: 10.1021/ar2002254. Epub 2012 Mar 13.

PMID:
22413937
17.

Photoinduced RNA interference.

Matsushita-Ishiodori Y, Ohtsuki T.

Acc Chem Res. 2012 Jul 17;45(7):1039-47. doi: 10.1021/ar200227n. Epub 2012 Feb 24.

PMID:
22360585
18.

Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).

Pan Q, Ramakrishnaiah V, Henry S, Fouraschen S, de Ruiter PE, Kwekkeboom J, Tilanus HW, Janssen HL, van der Laan LJ.

Gut. 2012 Sep;61(9):1330-9. doi: 10.1136/gutjnl-2011-300449. Epub 2011 Dec 23.

PMID:
22198713
19.

Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency.

Kwon YJ.

Acc Chem Res. 2012 Jul 17;45(7):1077-88. doi: 10.1021/ar200241v. Epub 2011 Nov 21.

PMID:
22103667
20.

Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.

Chaturvedi K, Ganguly K, Kulkarni AR, Kulkarni VH, Nadagouda MN, Rudzinski WE, Aminabhavi TM.

Expert Opin Drug Deliv. 2011 Nov;8(11):1455-68. doi: 10.1517/17425247.2011.610790. Epub 2011 Aug 26. Review.

PMID:
21867463
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk